Migraine Again on MSN

Why sumatriptan (Imitrex) for migraine relief may be worth revisiting

Imitrex (sumatriptan) was the first migraine medication approved to abort an attack. Discover its side effects, benefits, and ...

Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly

Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), ...

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity

Skye is planning to initiate a Phase 2b clinical trial in obesity for nimacimab with ENHANZE in the middle of 2026. This study will also assess the combination of nimacimab and a GLP-1R agonist.